← Leaderboards
Terence John O'Brien
University Of Southern California
$1,261,869
Attributed
$8,833,081
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,527,814 · 2
By mechanism
U54$21,694,733 · 1
R01$8,833,081 · 1
Top collaborators
- Aristea S Galanopoulou20 shared
- Denes Agoston10 shared
- Lisa D Coles10 shared
- Dominique Duncan10 shared
- Jerome None Engel10 shared
- Andrey M Mazarati10 shared
- Solomon L Moshe10 shared
- Asla Sl Pitkanen10 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Arthur W Toga$135,966,223
- Dominique Duncan$3,859,074
Others in their field
Other Emerging Leaders on “Traumatic Brain Injury”
- Sharon Dziuba Yeatts · University Of Michigan At Ann Arbor$9,194,955
- Lori Shutter · University Of Michigan At Ann Arbor$7,883,569
- Edmund R Hollis · Winifred Masterson Burke Med Res Inst$6,140,042
- Catherine Daniela Chong · Mayo Clinic Arizona$5,263,795
- Zhengxin Cai · Yale University$5,095,506
- Frederic Geissmann · Sloan-Kettering Inst Can Research$5,019,765
Research focus
Traumatic Brain InjuryAnimal ModelFutureBioinformaticsPreventPost-Traumatic EpilepsyAntiepileptogenicEpileptogenesisBiological MarkersEpilepsyPlasmaLateralRandomizedDesignImageInjuryFundingPre-ClinicalCollaborationsFluid Percussion InjuryInternationalInvestigationRattusBiomarker Panel
Grant awards (20)
Translational Platform for Epilepsy Therapy and Biomarker Discovery$2,036,071
R01 · FY2025 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$2,215,256
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$87,937
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$47,310
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$47,310
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$15,770
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$15,770
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$2,122,350
R01 · FY2023 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$16,204
R01 · FY2023 · NS
Translational platform for epilepsy therapy and biomarker discovery$2,229,103
R01 · FY2022 · NS
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)$4,245,953
U54 · FY2021 · NS
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)$37,498
U54 · FY2021 · NS
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)$4,251,932
U54 · FY2020 · NS
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)$37,498
U54 · FY2020 · NS
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)$4,209,866
U54 · FY2019 · NS
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)$37,498
U54 · FY2019 · NS
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)$4,282,449
U54 · FY2018 · NS
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)$37,498
U54 · FY2018 · NS
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)$4,517,043
U54 · FY2017 · NS
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)$37,498
U54 · FY2017 · NS